Rapid Assessment of Avoidable Blindness and Diabetic Retinopathy in Taif, Saudi Arabia
Overview
Affiliations
Background/aims: To estimate the prevalence of blindness, diabetes and diabetic retinopathy (DR) in Taif, Saudi Arabia using the Rapid Assessment of Avoidable Blindness (RAAB) framework.
Methods: 66 clusters of 50 people aged ≥50 years were randomly selected. Participants underwent visual acuity measurement and examination by an ophthalmologist. DR among diabetic participants (previous diagnosis and/or random blood glucose >200 mg/dl) was assessed through dilated fundus examination by an ophthalmologist using a direct and indirect ophthalmoscope ('clinical examination') and dilated digital fundus photographs graded by a retinal specialist following the Scottish DR grading system ('reference standard').
Results: 3052 (93%) out of 3300 eligible people were examined. The prevalence of blindness was 2.6% (95% CI 2.0% to 3.2%). Posterior segment diseases (44%) and cataract (41%) were the leading causes of blindness. The estimated prevalence of diabetes was 29.7% (28.1% to 31.4%), among whom the prevalence of DR was 36.8% (33.3% to 40.2%) and sight-threatening DR (STDR) was 17.5% (CI 15.1% to 20.0%). Agreement was good (κ>0.6) between the clinical examination and reference standard for any DR and STDR.
Conclusions: There was a high prevalence of diabetes, DR and STDR. It was possible to assess diabetes and DR within RAAB but it increased the survey duration, cost and complexity.
Association Between HbA1c Levels and the Severity of Diabetic Retinopathy.
Alswaina N Cureus. 2025; 16(12):e76395.
PMID: 39867069 PMC: 11762433. DOI: 10.7759/cureus.76395.
AlThani M, Abdulmalik M, AlAbdulla S, AlMotawaa K, Algadi H, Rabiu M Ophthalmic Res. 2025; 68(1):137-145.
PMID: 39837282 PMC: 11844693. DOI: 10.1159/000543721.
Alshahrani A, Alshahrani A, Al-Boqami B, Alqahtani A, Alzahrani B, Bassi Y Biomolecules. 2025; 14(12.
PMID: 39766193 PMC: 11727158. DOI: 10.3390/biom14121486.
Mohamed Z, Al-Natour M, Al Rahbi H Oman Med J. 2024; 39(1):e585.
PMID: 38651051 PMC: 11033453. DOI: 10.5001/omj.2024.77.
Control of diabetes, hypertension, and dyslipidemia in Jordan: a cross-sectional study.
Hyassat D, Abu Noor N, AlAjlouni Q, Jarrar Y, Qarajeh R, Mahasneh A Ann Med Surg (Lond). 2023; 85(3):439-445.
PMID: 37008178 PMC: 10060078. DOI: 10.1097/MS9.0000000000000272.